Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19212832 | 1.00 | SMYD3 (0.30) | SMYD3 | |
| SCHEMBL1710446 | 0.87 | MGLL (0.35) | — | |
| SCHEMBL26103771 | 0.87 | MGLL (0.35) | — | |
| SCHEMBL26103737 | 0.87 | MGLL (0.35) | — | |
| SCHEMBL21051957 | 0.85 | — | — | |
| SCHEMBL26105568 | 0.81 | MGLL (0.31) | — | |
| SCHEMBL2241400 | 0.78 | MGLL (0.43) | — | |
| Hydrochloric Acid SCHEMBL17310950 | 0.78 | CHRNA4 (0.38) | — | |
| SCHEMBL17113314 | 0.76 | RIPK1 (0.30) | — | |
| SCHEMBL14993512 | 0.72 | MBTD1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3414245-A1 | ANTIBACTERIAL COMPOUNDS | Redx Pharma Plc (GB) | 2018-12-19 | — | — | EP | disclosed |
| WO-2017137742-A1 | ANTIBACTERIAL COMPOUNDS | REDX PHARMA PLC (GB) | 2017-08-17 | — | — | WO | disclosed |
| EP-3122751-A1 | CONDENSED [1,4]DIAZEPINE COMPOUNDS AS AUTOTAXIN (ATX) AND LYSOPHOSPHATIDIC ACID (LPA) PRODUCTION INHIBITORS | F. Hoffmann-La Roche AG (CH) | 2017-02-01 | — | — | EP | disclosed |
| WO-2015144609-A1 | CONDENSED [1,4]DIAZEPINE COMPOUNDS AS AUTOTAXIN (ATX) AND LYSOPHOSPHATIDIC ACID (LPA) PRODUCTION INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2015-10-01 | — | — | WO | disclosed |